Rubius Therapeutics Inc (RUBY)
US$ 1.12-13.18%
Price Chart
Key Statistics
Market Cap
$ 5.16M
P/E Ratio
0.00
Revenue (TTM)
$ 0
Volume
21.01M
52W High
$ 0.00
52W Low
$ 0.00
Dividend Yield
0.00%
Beta
2.21
Technicals
50-Day MA
0.0217
200-Day MA
0.0199
52 Week High
N/A
52 Week Low
N/A
About RUBY
Rubius Therapeutics, Inc., a biopharmaceutical company, focuses on the development of red cell therapeutics for the treatment of cancer and autoimmune diseases.
Employees
6
Headquarters
Cambridge, MA
CEO
Ms. Dannielle Appelhans
Latest News
Ruby Evelyn Baker Obituary June 19, 2025 - McLane Funeral & Cremation Services
2 days ago • Google News
Ruby Franke's Son Chad Franke, 20, Gets Engaged to Girlfriend - E! Online
Yesterday • Google News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg